Cyclin D1 overexpression leads to an imbalance in CDK activity, which accelerates cell growth (even with limited mitotic signaling), bypasses key cell cycle checkpoints, and promotes tumor growth [14, 15]. Here, CCND1 is linked to neoplasm.